ams-OSRAM AG Unsponsored ADR (OTCMKTS:AMSSY – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $10.47, but opened at $10.93. ams-OSRAM shares last traded at $11.12, with a volume of 500 shares trading hands.
Wall Street Analysts Forecast Growth
Several analysts have commented on AMSSY shares. Jefferies Financial Group upgraded shares of ams-OSRAM from a “hold” rating to a “buy” rating in a report on Sunday, May 10th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of ams-OSRAM in a report on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.
View Our Latest Stock Report on AMSSY
ams-OSRAM Stock Performance
ams-OSRAM (OTCMKTS:AMSSY – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.26). ams-OSRAM had a negative return on equity of 7.17% and a negative net margin of 9.74%.The firm had revenue of $935.84 million during the quarter, compared to analysts’ expectations of $931.43 million. As a group, equities research analysts expect that ams-OSRAM AG Unsponsored ADR will post -0.07 earnings per share for the current year.
About ams-OSRAM
ams-OSRAM AG is a global technology company specializing in optical solutions, combining the sensor expertise of ams with the lighting heritage of OSRAM. The company develops and manufactures a broad range of high-performance products, including light-emitting diodes (LEDs), laser diode and infrared (IR) emitters, optical sensors, and sensor interfaces. These components are used across a variety of applications to enable advanced illumination, sensing, and imaging capabilities.
The company’s product portfolio serves diverse end markets such as consumer electronics, automotive, industrial, and medical.
See Also
- Five stocks we like better than ams-OSRAM
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for ams-OSRAM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ams-OSRAM and related companies with MarketBeat.com's FREE daily email newsletter.
